Leo Aubert

Montreal, QC H3T1J4, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression.

The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression.

Journal: Cell reports
Published: August 01, 2026

Acidosis Forces Fatty Acid Uptake and Metabolism in Cancer Cells Regardless of Genotype.

Acidosis Forces Fatty Acid Uptake and Metabolism in Cancer Cells Regardless of Genotype.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 25, 2025

IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia.

IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia.

Journal: Biomarker research
Published: November 06, 2024

Acid-exposed and hypoxic cancer cells do not overlap but are interdependent for unsaturated fatty acid resources.

Acid-exposed and hypoxic cancer cells do not overlap but are interdependent for unsaturated fatty acid resources.

Journal: Nature communications
Published: March 13, 2024

The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression.

The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression.

Journal: Cell reports
Published: December 15, 2023

Tumor acidosis-induced DNA damage response and tetraploidy enhance sensitivity to ATM and ATR inhibitors.

Tumor acidosis-induced DNA damage response and tetraploidy enhance sensitivity to ATM and ATR inhibitors.

Journal: EMBO reports
Published: October 08, 2023

Immunotherapeutic targeting of surfaceome heterogeneity in AML.

Immunotherapeutic targeting of surfaceome heterogeneity in AML.

Journal: Cell reports
Published: October 05, 2023

PPARα-mediated lipid metabolism reprogramming supports anti-EGFR therapy resistance in head and neck squamous cell carcinoma.

PPARα-mediated lipid metabolism reprogramming supports anti-EGFR therapy resistance in head and neck squamous cell carcinoma.

Journal: Nature communications
Published: July 14, 2023

CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216.

CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216.

Journal: Blood advances
Published: September 08, 2022

Direct interaction of TrkA/CD44v3 is essential for NGF-promoted aggressiveness of breast cancer cells.

Direct interaction of TrkA/CD44v3 is essential for NGF-promoted aggressiveness of breast cancer cells.

Journal: Journal of experimental & clinical cancer research : CR
Published: November 19, 2021

Targeting copper metabolism to defeat KRAS-driven colorectal cancer.

Targeting copper metabolism to defeat KRAS-driven colorectal cancer.

Journal: Molecular & cellular oncology
Published: November 25, 2020

Proteomic Analysis Reveals a Role for RSK in p120-catenin Phosphorylation and Melanoma Cell-Cell Adhesion.

Proteomic Analysis Reveals a Role for RSK in p120-catenin Phosphorylation and Melanoma Cell-Cell Adhesion.

Journal: Molecular & cellular proteomics : MCP
Published: October 07, 2019
Showing 1-12 of 21

Last Updated: 09/26/2026